NSC |
Compound |
Enrichment |
Correlation |
NSC 685014 |
Null |
0.0283958753782624 |
0.068595813 |
NSC 724631 |
4,11-dihydroxy-1-[4-[[2-hydroxy-1-(hydroxymethyl)-1-methylet hyl]-mino]butyl]-1H-naphtho[2,3-f]indole-5,10-dione |
0.0283958753782624 |
0.2960238 |
NSC 734562 |
6-(3-Aminopropyl)-9-bromo-5,6-dihydro-3-nitro-5,11-dioxo-11H -indeno[1,2-c]isoquinoline Hydrochloride |
0.0283958753782624 |
0.19973168 |
NSC 756166 |
GSK312948A |
0.0283958753782624 |
0.043403447 |
NSC 763646 |
(E)-2-(2-(benzo[d][1,3]dioxol-5-yl)vinyl)-5-(3-methyl-1H-pyrazol-5-yl)-1,3,4-oxadiazole |
0.0283958753782624 |
0.089726479 |
NSC 705871 |
1H-Indole, 5-bromo-3-[2-(2-pyridinyl)-4-thiazolyl]- |
0.0284045326811616 |
0.13921656 |
NSC 715664 |
Phenol, 4-(5,6-dimethyl-1H-benzimidazol-2-yl)- 2,6-bis(1,1-dimethylethyl)- |
0.0284045326811616 |
0.13657692 |
NSC 726718 |
3-(Benzothiazol-6-ylamino)-7-chloro-8-methyl-1,1,-dioxo-4H-1 ,5,2-benzodithiazepin-4-ylideneacetic acid |
0.0284045326811616 |
0.23674865 |
NSC 727985 |
NSC 708781 incorporated in micelles, 0.55% (w/w) of drug |
0.0284045326811616 |
0.0092072279 |
NSC 731155 |
6-(3-Aminopropyl)-5,6-dihydro-5,11-dioxo-3-nitro-11H-indeno[ 1,2-c]isoquinoline Hydrochloride salt |
0.0284045326811616 |
0.17456983 |